Aurobindo Pharma Ltd.

In News

Aurobindo Pharma stock slides over 5% after USFDA classifies Eugia facility as ‘OAI’ - Moneycontrol.com

Moneycontrol.com - Jun 15, 2026

Aurobindo Pharma Ltd leads losers in 'A' group - Business Standard

Business Standard - Jun 15, 2026

Aurobindo Pharma shares fall after USFDA flags Eugia Unit III with OAI status - CNBC TV18

CNBC TV18 - Jun 15, 2026

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA - Indian Pharma Post

Indian Pharma Post - Jun 09, 2026

Aurobindo Pharma's Eugia Unit-III Receives OAI Status from USFDA - Medical Dialogues

Medical Dialogues - Jun 13, 2026

Aurobindo Pharma Falls 2% After USFDA Classifies Eugia Unit III as OAI - Equitypandit

Equitypandit - Jun 15, 2026

BDA advises Khandelwal Labs on sale of non-oncology branded generics business to Aurobindo - BDA Partners

BDA Partners - Jan 05, 2026

Aurobindo Pharma Limited (NSE:AUROPHARMA) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹1,466 - simplywall.st

simplywall.st - May 24, 2026

Claim your share of the $2M Aurobindo Irbesartan drug contamination class action settlement - Claim Depot

Claim Depot - Apr 06, 2026

Aurobindo Pharma to attend Goldman Sachs investor meet - scanx.trade

scanx.trade - Jun 09, 2026

Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims - Law360

Law360 - Jan 09, 2026

Aurobindo Pharma shares slip after USFDA classifies Eugia facility as OAI - Moneycontrol.com

Moneycontrol.com - Jun 15, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment